verified SJR 0,926 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · John Wiley and Sons Inc

workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Haemophilia

Haemophilia is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 107. It has a price of 2083 €. It has an SJR impact factor of 0,926 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,926.

Haemophilia focuses its scope in these topics and keywords: haemophilia, musculoskeletal, haemophilic, exercise, therapy, approaches, adults, arthropathy, activity, detects, ...

ISSN: 1351-8216

Publisher: John Wiley and Sons Inc

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,926 Q1

H-index 107

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.083 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,926

H-index

107

Docs (year)

208

Docs 3y

704

Total refs

5931

Cites 3y

1579

Citable 3y

499

Cites/Doc 2y

2.05

Ref/Doc

28.51

Immediate OA

2083 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Conference Introduction

World Federation of Hemophilia Developing World Programmes

European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients

Ethics of haemophilia care in the developing world

Economic evaluation: what are we looking for and how do we get there?

Distribution and treatment of haemophiliacs

Dilemmas in treatment: the patient's dilemma

Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant

Development and validation of a measure of disease-specific quality of life in young children with haemophilia

Danazol therapy in factor X deficiency: more questions than answers

Cryoprecipitate-removed plasma 'cryo-removed plasma' as a source of factor IX in the treatment of haemophilia B

Cryoprecipitate and the plastic blood-bag system

SHOW MORE ARTICLES

Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience

A case-control study on the psychological aspects and coping in haemophilic patients

Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis - another rebuttal

Commentary on book review: A History of Blood Coagulation

Clinical outcomes and resource utilization associated with haemophilia care in Europe

Carrier detection and prenatal diagnosis in haemophilia in India: realities and challenges

Call for post-licensing human pharmacokinetic studies of administration of recombinant factor IX

Aspects of haemophilia prophylaxis in Sweden

Approaches to funding: Swedish cost-effectiveness study

Additional data on the morbidity of central venous access devices in patients with Haemophilia

Acquired anti-FVIII inhibitors in children

Access to medical information in Spain

FAQs

Haemophilia has an SJR of 0,926 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2083 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Haemophilia is 25%.

Haemophilia

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Haemophilia?

What is the APC / publication cost?

What is the acceptance rate?